Epilepsy syndromes in cerebral palsy: varied, evolving and mostly self-limited

Monica S Cooper1,2,3, Mark T Mackay1,2,3, Charuta Dagia1,2

  • 1The Royal Children's Hospital, Melbourne, Victoria 3052, Australia.

Insights

Children with cerebral palsy (CP) and seizures often have specific epilepsy syndromes, commonly self-limited focal epilepsy-variant. These diagnoses inform treatment and prognosis for pediatric epilepsy in CP.

Area of Science:

  • Neurology
  • Pediatrics
  • Epileptology

Background:

  • Seizures affect approximately one-third of children with cerebral palsy (CP).
  • Understanding epilepsy syndromes in CP due to vascular injury is crucial for treatment and prognosis.
  • Previous research often excluded children with CP from epilepsy syndrome classifications.

Purpose of the Study:

  • To determine specific epilepsy syndromes in children with CP resulting from vascular injury.
  • To investigate the prevalence of different epilepsy syndromes in this cohort.
  • To correlate epilepsy syndromes with clinical features and seizure outcomes.

Main Methods:

  • Population-based cohort study of children with CP due to prenatal/perinatal vascular injuries (born 1999-2006).
  • Review of MRI to characterize brain injury patterns.
  • Chart review, parent interviews, and EEGs to diagnose epilepsy syndromes and assess outcomes.
  • Exclusion of children with syndromic or genetic CP to ensure cohort homogeneity.

Main Results:

  • Of 256 children, 93 (36%) experienced seizures, and 87 (34%) had epilepsy.
  • Self-limited focal epilepsy-variant was diagnosed in 56 children (60% of those with seizures), often presenting with autonomic and brachio-facial features and centro-temporal/occipital spikes.
  • Seventy-five percent of children with self-limited focal epilepsy-variant achieved seizure freedom (>2 years).
  • Overall, 67% of children with CP and seizures were seizure-free at mean age 15 years.
  • Other identified syndromes included focal epilepsy-not otherwise specified, infantile spasms syndrome, Lennox-Gastaut syndrome, and genetic generalized epilepsies.

Conclusions:

  • Children with CP and seizures can be classified into specific epilepsy syndromes, many of which are age-dependent and self-limited.
  • Self-limited focal epilepsy-variant is more common in children with CP and epilepsy than in typically developing children.
  • These findings support tailored treatment strategies and improved prognostic accuracy for epilepsy in pediatric cerebral palsy.

Related Concept Videos

Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
574
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
269
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
591
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
690
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
833
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
497